Extramedullary facial plasmacytomas with anaplastic features: A diagnostic dilemma with implications for treatment

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 21, Issue 4, 1998, Pages 401-405

  Aboulafia, David M ^a   Lee, Roger M ^a   Hafermann, Mark ^a   Chu, Felix W K ^a   Fenske, Maria ^a  

^a VIRGINIA MASON MEDICAL CENTER   (United States)

Author keywords

Anaplastic myeloma; Plasmacytoma; Richter transformation

Indexed keywords

ADULT; ANAPLASTIC CARCINOMA; ARTICLE; BIOPSY; BLAST TRANSFORMATION; CANCER GRADING; CASE REPORT; CELL DIFFERENTIATION; CELL INFILTRATION; FACE TUMOR; HUMAN; MALE; MALIGNANT TRANSFORMATION; PLASMA CELL DYSCRASIA; PLASMACYTOMA; SOFT TISSUE TUMOR;

ADULT; BONE NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; COMBINED MODALITY THERAPY; FACIAL NEOPLASMS; HUMANS; MALE; MULTIPLE MYELOMA; NEOPLASM RECURRENCE, LOCAL; PLASMACYTOMA; SOFT TISSUE NEOPLASMS;

EID: 0031867713     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199808000-00017     Document Type: Article

References (26)

1. Joshua DE, Gibson J. Diagnosis and treatment of multiple myeloma. In: Weirnek PH, Cannelos GP, Dutcher JP, Kyle RA, eds. Neoplastic disease of the blood. 3rd ed. New York: Churchill Livingstone, 1996:563-81.
2. Dimopoulos MA, Moulopoulos A, Delasalle K, Alexanian R. Solitary plasmacytoma of bone and asymptomatic multiple myeloma. Hematol Oncol Clin North Am 1992;6:359-68.
3. Kapadia SB, Desai Y, Cheng VS. Extramedullary plasmacytoma of the head and neck. Medicine 1982;61:317-29.
4. Foucar K, Raber M, Foucar E, Barlogie B, Saundler CM, Alexanian R. Anaplastic myeloma with massive extramedullary involvement. Cancer 1983;51:166-74.
5. Falini B, De Solas I, Levine AM, Parker JW, Lukes RJ, Saletan S. Aggressive plasma cell myeloma: a terminal complication. Arch Intern Med 1981;141:1315-20.
6. Zervas K, Constantinou N, Karakantza M, Tsigalidou-Balla V. Anaplastic myeloma. Leuk Lymphoma 1995;16:515-8.
7. Di Stasi M, Cavanna L, Paties C, et al. Anaplastic myeloma as extramedullary relapse of multiple myeloma in remission. case report and review of the literature. Acta Haematol 1986;76:202-7.
8. Chao NJ, Rosenberg SA, Horning SJ. CEPP(B): an effective and well-tolerated regimen in poor-risk, aggressive non-Hodgkin's lymphoma. Blood 1990;76:1293-8.
9. Bergsagel DE, Pruzanski W. Syndromes and special presentations associated with multiple myeloma. In: Weirnek PH, Cannelos GP, Dutcher JP, Kyle RA, eds. Neoplastic disease of the blood. 3rd ed. New York: Churchill Livingstone, 1996:585-7.
10. Frassica DA, Frassica FJ, Schray MF, Sim FH, Kyle RA. Solitary plasmacytoma of bone: Mayo Clinic experience. Int J Radiat Oncol Biol Phys 1989;16:43-8.
11. Holland J, Trenker DA, Wasserman TH, Fineberg B. Plasmacytoma. treatment results and conversion to myeloma. Cancer 1992;69:1513-7.
12. Kyle RA, Schreiman JS, McLeod RA, Beabout JW. Computed tomography in diagnosis and management of multiple myeloma and its variants. Arch Intern Med 1985;145:1451-2.
13. Moulopoulos LA, Dimopoulous M, Weber D, Fuller L, Lipshitz HI, Alexanian R. Magnetic imaging in the staging of solitary plasmacytoma of bone. J Clin Oncol 1993;11:1311-5.
14. Krespi YP, Levine TM. Tumors of the nose and paranasal sinuses. In: Paparella MM, Shunrick D, Gluckman JL, Meyerhoff WL, eds. Otolaryngology: head and neck. 3rd ed. Philadelphia: WB Saunders, 1991:1942.
15. Hedinger E. Zuir frage des plasmacytomas. Frankfurt Zeitchrift Pathologie 1911;7:343-50.
16. Chang YT, Wong CK. Primary cutaneous plasmacytomas. Clin Exp Dermatol 1994;19:177-80.
17. Batsakis JG. Pathology consultation, plasma cell tumors of the head and neck. Ann Otol Rhinol Laryngol 1983;92:311-3.
18. Panosian MS, Roberts JK. Plasmacytoma of the middle ear and mastoid. Am J Otol 1994;15:264-7.
19. Knowling MA, Harwood AR, Bergsagel DE. Comparison of extramedullary plasmacytomas with solitary and multiple plasma cell tumors of bone. J Clin Oncol 1983;1:255-62.
20. Meis JM, Butler JJ, Osborne BM, Ordonez NG. Solitary plasmacytomas of bone and extramedullary plasmacytomas. a clinicopathologic and immunohistochemical study. Cancer 1987;59:1475-85.
21. Soesan M, Paccagnella A, Chiarion-Sileni V, et al. Extramedullary plasmacytoma: clinical behavior and response to treatment. Ann Oncol 1992;3:51-7.
22. Strand WR, Banks PM, Kyle RA. Anaplastic plasma cell myeloma and immunoblastic lymphoma. clinical, pathologic, and immunologic comparison. Am J Med 1984;76:861-7.
23. Suchman AL, Coleman M, Mouradian JA, Wolf DJ, Saletan S. Aggressive plasma cell myeloma. a terminal phase. Arch Intern Med 1981;141:1315-20.
24. Oken MM. Multiple myeloma: prognosis and standard treatment. Cancer Invest 1997;15:57-64.
25. Sanal SM, Yaylaci M, Mangold KA, Pantazis CG. Extensive extramedullary disease in myeloma. an uncommon variant with features of poor prognosis and dedifferentiation. Cancer 1996;77:1298-302.
26. Falini B, DeSolas I, Levine AM, Parker JW, Lukes RJ, Taylor CR. Emergence of B-immunoblastic sarcoma in patients with multiple myeloma: a clinicopathologic study of 10 cases. Blood 1982;59:923-33.